DekaBank Deutsche Girozentrale Purchases 238,285 Shares of Avantor, Inc. (NYSE:AVTR)

DekaBank Deutsche Girozentrale grew its position in shares of Avantor, Inc. (NYSE:AVTR) by 146.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 400,736 shares of the company’s stock after buying an additional 238,285 shares during the period. DekaBank Deutsche Girozentrale owned 0.06% of Avantor worth $10,205,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Graypoint LLC lifted its position in shares of Avantor by 3.8% during the first quarter. Graypoint LLC now owns 11,414 shares of the company’s stock worth $292,000 after acquiring an additional 423 shares in the last quarter. Vontobel Holding Ltd. grew its holdings in Avantor by 2.0% during the 4th quarter. Vontobel Holding Ltd. now owns 30,215 shares of the company’s stock valued at $690,000 after buying an additional 591 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. increased its position in shares of Avantor by 3.8% during the fourth quarter. Tokio Marine Asset Management Co. Ltd. now owns 18,725 shares of the company’s stock valued at $427,000 after buying an additional 685 shares during the period. Fifth Third Bancorp lifted its holdings in shares of Avantor by 125.3% in the fourth quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock worth $28,000 after buying an additional 694 shares in the last quarter. Finally, Mackenzie Financial Corp boosted its position in shares of Avantor by 1.6% in the fourth quarter. Mackenzie Financial Corp now owns 46,610 shares of the company’s stock valued at $1,064,000 after acquiring an additional 747 shares during the period. Institutional investors own 95.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on AVTR shares. Deutsche Bank Aktiengesellschaft raised their price target on Avantor from $23.00 to $25.00 and gave the company a “hold” rating in a report on Thursday, April 18th. Morgan Stanley lifted their target price on shares of Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a research report on Monday, July 29th. Citigroup lowered shares of Avantor from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $30.00 to $23.00 in a report on Wednesday, July 10th. TD Cowen lifted their price objective on shares of Avantor from $28.00 to $31.00 and gave the stock a “buy” rating in a report on Monday, July 29th. Finally, Robert W. Baird increased their target price on Avantor from $26.00 to $27.00 and gave the company an “outperform” rating in a research note on Monday, July 29th. Four research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $27.21.

Avantor Stock Down 3.4 %

AVTR traded down $0.90 during midday trading on Friday, reaching $25.60. The company’s stock had a trading volume of 11,282,011 shares, compared to its average volume of 15,055,082. The stock’s 50-day moving average is $22.59 and its 200-day moving average is $23.79. Avantor, Inc. has a 1 year low of $16.63 and a 1 year high of $28.00. The firm has a market capitalization of $17.40 billion, a price-to-earnings ratio of 65.64, a PEG ratio of 2.71 and a beta of 1.32. The company has a current ratio of 1.59, a quick ratio of 1.05 and a debt-to-equity ratio of 0.89.

Insider Buying and Selling

In related news, insider Christophe Couturier 10,000 shares of the firm’s stock in a transaction on Tuesday, July 30th. The was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.50% of the stock is currently owned by company insiders.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.